Back to search
FDAFDA · Food and drugs·Recall number D-0270-2023

New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%).

Published February 22, 2023 · Recall initiated: February 9, 2023

Summary

FDA records drug Class II recall D-0270-2023, published February 22, 2023 and initiated February 9, 2023. Recalling firm: HTO Nevada, Inc.; Status: Terminated; Reported quantity: 4709 bottles; Lot: Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
HTO Nevada, Inc.
Distributor
Nationwide in the USA and Canada.
Lot
Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%). recalled?

Yes. FDA published recall D-0270-2023 on February 22, 2023. Reported hazard: cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

What should I do if I have this product?

Voluntary: Firm initiated · Letter